Tool for Predicting Clinical Immunogenicity
An in vitro tool for predicting clinical immunogenicity of subcutaneously administered therapeutic proteins
Published: 12th May 2022

Patents
- US Provisional Patent Application 63/321,057 filed March 17, 2022.
IP Status
- Provisional patent
- Patent application submitted
Seeking
- Licensing
- Commercial partner
- Development partner